• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膳食钠与原发性高血压:一些误区、期望与真相。

Dietary sodium and essential hypertension: some myths, hopes, and truths.

作者信息

Laragh J H, Pecker M S

出版信息

Ann Intern Med. 1983 May;98(5 Pt 2):735-43. doi: 10.7326/0003-4819-98-5-735.

DOI:10.7326/0003-4819-98-5-735
PMID:6847013
Abstract

Rigorous sodium deprivation can lower the blood pressure of some patients with essential hypertension (at best, 30% to 50% of patients). In the rest, sodium depletion is ineffective and, in some instances, can raise the blood pressure and cause adverse clinical effects. In normal persons, it is difficult to affect blood pressure even with drastic changes in salt intake; for the blood pressure to rise even slightly, it may be necessary to consume more than 800 meq/d. There is no evidence to indicate that a widely applied, moderate reduction of salt intake could prevent the development of hypertension. The evidence suggesting that such moderate salt intake would significantly lower blood pressure in the patients with sodium-sensitive essential hypertension is weak. Human hypertension comprises a heterogeneous spectrum of abnormal vasoconstriction-volume interactions. Sodium deprivation, like other forms of therapy, should be applied only to those patients in whom its effectiveness has been established.

摘要

严格的钠缺失可降低部分原发性高血压患者的血压(最多可使30%至50%的患者血压降低)。对于其余患者,钠缺失无效,而且在某些情况下,还会使血压升高并产生不良临床影响。在正常人中,即使盐摄入量发生剧烈变化,也很难影响血压;要使血压稍有升高,可能需要每天摄入超过800毫当量的盐。没有证据表明广泛应用的适度减少盐摄入量可预防高血压的发生。有证据表明,适度减少盐摄入量会使钠敏感性原发性高血压患者的血压显著降低,但其证据并不充分。人类高血压包括一系列异常的血管收缩 - 血容量相互作用。与其他治疗方法一样,钠缺失疗法应仅应用于已证实其有效性的患者。

相似文献

1
Dietary sodium and essential hypertension: some myths, hopes, and truths.膳食钠与原发性高血压:一些误区、期望与真相。
Ann Intern Med. 1983 May;98(5 Pt 2):735-43. doi: 10.7326/0003-4819-98-5-735.
2
Human essential hypertension: implications of animal studies.人类原发性高血压:动物研究的启示
Ann Intern Med. 1983 May;98(5 Pt 2):729-34. doi: 10.7326/0003-4819-98-5-729.
3
Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.盐摄入对高血压发病机制及治疗的影响
Adv Exp Med Biol. 2017;956:61-84. doi: 10.1007/5584_2016_147.
4
Chronology of the sodium hypothesis and hypertension.钠假说与高血压的时间线。
Ann Intern Med. 1983 May;98(5 Pt 2):720-3. doi: 10.7326/0003-4819-98-5-720.
5
Sodium and hypertension. A review.钠与高血压。综述。
Arch Intern Med. 1986 Jan;146(1):179-85.
6
Sodium intake and hypertension: a cause for concern.钠摄入与高血压:一个值得关注的问题。
Ann Intern Med. 1983 May;98(5 Pt 2):724-8. doi: 10.7326/0003-4819-98-5-724.
7
[Sodium and hypertension].[钠与高血压]
Arch Mal Coeur Vaiss. 1996 Sep;89 Spec No 4:9-15.
8
Sodium is more important than calcium in essential hypertension.在原发性高血压中,钠比钙更重要。
Hypertension. 1985 Jul-Aug;7(4):628-40. doi: 10.1161/01.hyp.7.4.628.
9
Divergent blood pressure responses during short-term sodium restriction in hypertension.高血压患者短期限钠期间血压反应的差异
Clin Pharmacol Ther. 1980 Apr;27(4):544-6. doi: 10.1038/clpt.1980.76.
10
The antihypertensive mechanism of sodium restriction.钠限制的降压机制。
J Cardiovasc Pharmacol. 1981 Jul-Aug;3(4):781-90. doi: 10.1097/00005344-198107000-00011.

引用本文的文献

1
Association of SLC34A2 variation and sodium-lithium countertransport activity in humans and baboons.人类和狒狒中SLC34A2变异与钠-锂逆向转运活性的关联
Am J Hypertens. 2009 Mar;22(3):288-93. doi: 10.1038/ajh.2008.355. Epub 2009 Jan 1.
2
Electrolyte intake and blood pressure: a study in contradictions and controversy.
Klin Wochenschr. 1985 Sep 2;63(17):788-92. doi: 10.1007/BF01732282.
3
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.高胰岛素血症。高血压、肥胖与葡萄糖耐量异常之间的联系。
J Clin Invest. 1985 Mar;75(3):809-17. doi: 10.1172/JCI111776.
4
[Salt and blood pressure].
Soz Praventivmed. 1986;31(4-5):262-6. doi: 10.1007/BF02083482.
5
Sodium and hypertension. Still a controversy in 1986.
Drugs. 1986;31 Suppl 4:29-39. doi: 10.2165/00003495-198600314-00005.
6
Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia.1989年3月21日至23日在新斯科舍省哈利法克斯举行的加拿大高血压非药物治疗方法共识会议的建议。
CMAJ. 1990 Jun 15;142(12):1397-409.